NewsWhore
03-23-2011, 04:20 PM
for the development and commercialization of its migraine treatment in Brazil, Colombia, Ecuador and Peru. Chapel Hill-based Pozen (Nasdaq: POZN) previously licensed U.S. rights of the treatment, ...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/44022382/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/44022382/)